These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 3669760

  • 21. Skeletal complications in hairy cell leukemia: diagnosis and therapy.
    Lembersky BC, Ratain MJ, Golomb HM.
    J Clin Oncol; 1988 Aug; 6(8):1280-4. PubMed ID: 3411340
    [Abstract] [Full Text] [Related]

  • 22. Hematologic and immunologic changes in hairy cell leukemia patients treated with alpha interferon.
    Turhan AG, Eaves CJ, Connors JM, Eaves AC, Karim KA, Silver KB.
    J Biol Regul Homeost Agents; 1988 Aug; 2(4):157-65. PubMed ID: 2907963
    [Abstract] [Full Text] [Related]

  • 23. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
    Ratain MJ, Golomb HM, Vardiman JW, Westbrook CA, Barker C, Hooberman A, Bitter MA, Daly K.
    J Clin Oncol; 1988 Nov; 6(11):1714-21. PubMed ID: 3054003
    [Abstract] [Full Text] [Related]

  • 24. The role of interferon in the treatment of hairy cell leukemia.
    Ratain MJ, Vardiman JW, Golomb HM.
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):21-8. PubMed ID: 3532332
    [Abstract] [Full Text] [Related]

  • 25. Hairy cell leukemia: a model for studying the B cell family of diseases.
    Al-Katib A, Berman E, Black P, Koziner B.
    Semin Oncol; 1986 Dec; 13(4 Suppl 5):48-54. PubMed ID: 3492047
    [Abstract] [Full Text] [Related]

  • 26. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
    Babuŝíková O, Tomová A, Kusenda J, Gyárfás J.
    Neoplasma; 2001 Dec; 48(5):350-7. PubMed ID: 11845978
    [Abstract] [Full Text] [Related]

  • 27. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
    Gastl G, Werter M, De Pauw B, Nerl C, Aulitzky W, von Lüttichau I, Tilg H, Thaler J, Lang A, Abbrederis K.
    Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
    [Abstract] [Full Text] [Related]

  • 28. [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].
    Niederle N, Doberauer C, Kloke O, Höffken K, Schmidt CG.
    Klin Wochenschr; 1987 Jul 15; 65(14):706-12. PubMed ID: 3114551
    [Abstract] [Full Text] [Related]

  • 29. Recombinant alpha-2 interferon in the treatment of hairy cell leukemia.
    Thompson JA, Brady J, Kidd P, Fefer A.
    Cancer Treat Rep; 1985 Jul 15; 69(7-8):791-3. PubMed ID: 4016788
    [Abstract] [Full Text] [Related]

  • 30. Effect of alpha-interferon therapy on bone marrow fibrosis in hairy cell leukemia.
    Laughlin M, Islam A, Barcos M, Meade P, Ozer H, Gavigan M, Henderson E, Han T.
    Blood; 1988 Sep 15; 72(3):936-9. PubMed ID: 3416078
    [Abstract] [Full Text] [Related]

  • 31. Interferon alpha in the treatment of hairy cell leukemia.
    Castaigne S, Sigaux F, Cantell K, Falcoff E, Boiron M, Flandrin G, Degos L.
    Cancer; 1986 Apr 15; 57(8 Suppl):1681-4. PubMed ID: 3948138
    [Abstract] [Full Text] [Related]

  • 32. Peripheral and intrasplenic platelet kinetics and bone marrow megakaryopoiesis in alpha-2b-interferon treated hairy cell leukemia.
    Wadenvik H, Braide I, Ridell B, Kutti J, Jacobsson S, Revesz P.
    Leuk Res; 1994 Aug 15; 18(8):569-75. PubMed ID: 8065159
    [Abstract] [Full Text] [Related]

  • 33. [Low dosage long-term treatment with recombinant alpha interferon induces in hairy cell leukemia continuous complete remission].
    Erlacher L, Gisslinger H, Chott A.
    Wien Klin Wochenschr; 1991 Aug 15; 103(19):588-90. PubMed ID: 1759461
    [Abstract] [Full Text] [Related]

  • 34. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
    Glaspy JA, Souza L, Scates S, Narachi M, Blatt L, Ambersley J, Golde DW.
    J Immunother (1991); 1992 Apr 15; 11(3):198-208. PubMed ID: 1381218
    [Abstract] [Full Text] [Related]

  • 35. Treatment of hairy cell leukemia: the Ohio State University experience with deoxycoformycin.
    Bouroncle BA, Grever MR, Kraut EH.
    Leukemia; 1987 Apr 15; 1(4):350-4. PubMed ID: 3499542
    [Abstract] [Full Text] [Related]

  • 36. Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemia.
    Thaler J, Dietze O, Faber V, Greil R, Gastl G, Denz H, Ho AD, Huber H.
    Leukemia; 1990 Mar 15; 4(3):170-6. PubMed ID: 2314116
    [Abstract] [Full Text] [Related]

  • 37. Human lymphoblastoid interferon for hairy cell leukemia: results from the Italian Cooperative Group.
    Damasio EE, Bernasconi C, Castoldi GL, Chisesi T, Federico M, Lamparelli T, Lauria F, Pagnucco G, Resegoti L, Rossi E.
    Leukemia; 1987 Apr 15; 1(4):331-3. PubMed ID: 3669757
    [Abstract] [Full Text] [Related]

  • 38. [Results of a multicenter study of the efficacy of recombinant alpha-2c interferon in hairy cell leukemia].
    Werter MJ, Bogman MJ, Janssen JT, de Pauw BE, Haanen CA.
    Ned Tijdschr Geneeskd; 1987 Nov 14; 131(46):2081-5. PubMed ID: 3683637
    [No Abstract] [Full Text] [Related]

  • 39. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
    Hasselbalch H, Braide I, Lisse I, Röckert LL, Swolin B, Carneskog J, Hagberg H, Hippe E, Jensen MK, Lundin P.
    Eur J Haematol; 1988 Nov 14; 41(5):438-44. PubMed ID: 3061836
    [Abstract] [Full Text] [Related]

  • 40. Changes in hairy cells after alpha-interferon treatment as measured by flow cytometry.
    Huang AT, Mold NG.
    Leukemia; 1987 Apr 14; 1(4):308-11. PubMed ID: 3669751
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.